Metformin DC Granules
Type 2 Diabetes Mellitus
CommercialMarketed
Key Facts
About Vistin Pharma
Vistin Pharma's mission is to be a leading global supplier of high-quality Metformin API, balancing growth with sustainable and responsible manufacturing. The company has achieved a defensible market position as Europe's dedicated producer, supplying ~10% of global demand to a diverse client base of international pharmaceutical companies. Its core strategy is focused on operational excellence and cost leadership in a single API, currently executing a capacity expansion to >7,000 MT/year to capture a larger share of the growing diabetes market. Financial performance is characterized by sustained revenue growth, underpinned by its specialized manufacturing platform.
View full company profileTherapeutic Areas
Other Type 2 Diabetes Mellitus Drugs
| Drug | Company | Phase |
|---|---|---|
| Type 2 Diabetes Program | Clinical Research of Philadelphia | Various (Typically Phase 2-4) |
| JTT-662 | Akros Pharma | Phase1 |
| SGLT2 Inhibitor (Innovative NCE) | Shenzhen Salubris Pharmaceuticals | Phase III |
| Novel Anti-diabetic Agent (Dual/Triple Agonist) | Shenzhen Salubris Pharmaceuticals | Phase II |
| Metformin HCl API | Vistin Pharma | Commercial |